What are the indications for use of an ARNI, Ivabradine, and SGLT2 Inhibitor?
The indications for Use of an ARNI are HFrEF (EF #40%), NYHA class II IV HF, and it is administered in conjunction with a background of GDMT for HF in place of an ACEI or ARB. The indications for Use of Ivabradine are HFrEF (EF #35%), On maximum tolerated dose of beta-blocker, Sinus rhythm with a resting heart rate 70 beats/min, and NYHA class II or III HF. The indications for Use of an SGLT2 Inhibitor are HFrEF (EF #40%) with or without diabetes, NYHA class II IV HF, and it is administered in conjunction with a background of GDMT for HF.